Skip to main content

Your search for “Infectious Diseases” returned 330 results

SDSC’s Comet Supercomputer, TSCC Available for COVID-19 Research

April 8, 2020

The San Diego Supercomputer Center at UC San Diego is providing priority access to its high-performance computer systems and other resources to researchers advancing our understanding of the virus and efforts to develop an effective vaccine in as short a time as possible.

A Novel COVID-19 Vaccine Using Modified Bacterial DNA

July 21, 2022

UC San Diego researchers describe a different way to build a COVID-19 vaccine, one that would, in theory, remain effective against new and emerging variants and could be taken as a pill, by inhalation or other delivery methods.

Quest for Edible Malarial Vaccine Leads to Other Potential Medical Uses for Algae

April 19, 2013

Can scientists rid malaria from the Third World by simply feeding algae genetically engineered with a vaccine? That’s the question biologists at UC San Diego sought to answer after they demonstrated last May that algae can be engineered to produce a vaccine that blocks malaria transmission. In a follow up…

Cat Bacteria Treats Mouse Skin Infection, May Help You and Your Pets As Well

October 19, 2021

Researchers at UC San Diego School of Medicine identify a strain of bacteria on healthy cats that produces antibiotics against severe skin infections. The findings may soon lead to new bacteriotherapies for humans and their pets, wherein cat bacteria is applied via topical cream or spray.

A Nanomaterial Path Forward for COVID-19 Vaccine Development

July 15, 2020

From mRNA vaccines entering clinical trials, to peptide-based vaccines and using molecular farming to scale vaccine production, the COVID-19 pandemic is pushing new and emerging nanotechnologies into the frontlines and the headlines.

Unprecedented Case Series Advances Promise of Phage Therapy

June 9, 2022

An international team of researchers, led by scientists at University of California San Diego School of Medicine and the University of Pittsburgh, report promising results from the largest case series yet of patients treated with bacteriophage therapy for antibiotic-resistant infections.

Does Blood Plasma from COVID-19 Survivors Help Patients Infected with Novel Coronavirus?

July 9, 2020

Researchers at University of California San Diego School of Medicine and UC San Diego Health have launched a clinical trial to assess the safety and efficacy of convalescent plasma (CP) to prevent COVID-19 after a known exposure to the virus.

Two UC San Diego Biologists Named Pew Scholars

June 14, 2018

The Pew Charitable Trusts has announced that UC San Diego Biological Sciences Assistant Professors Matthew Daugherty and Enfu Hui have been selected to the 2018 class of Pew Scholars in the Biomedical Sciences. Pew also announced that Diego Alvarez and Grisel Cruz Becerra, Biological Sciences postdoctoral researchers, have been named…

Therapeutic Potential of Bizarre ‘Jumbo’ Viruses Tapped for $10M HHMI Emerging Pathogens Project

January 26, 2023

UC San Diego and its collaborating partners have been awarded $10 million from the Howard Hughes Medical Institute to leverage the biomedical promise of viruses known as bacteriophages as new therapeutic agents in the fight against the rising crisis of antibiotic-resistant bacterial infections.

New Resource Harmonizes 16S and Shotgun Sequencing Data for Microbiome Research

July 27, 2023

UC San Diego scientists debut Greengenes2, a massive reference database that could be used to reconcile years of microbiome studies.

Category navigation with Social links